Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Two different studies found that Vemlidy was safe and effective for pregnant women and their infants.
Regardless of cirrhosis status, Mavyret led to high sustained virologic response rates in Latinos and other groups with hep C.
Despite new guidelines, too few infants born to mothers with hepatitis C were screened for the virus.
Racial differences in waiting list placement improved in states that expanded Medicaid.
Areas with lower population density have not seen the same slowdown as urban areas.
Requiring sobriety prior to treatment and curtailing harm reduction hinder efforts to eliminate hep C.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.